Humalog Mix50/50 KwikPen is a Subcutaneous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Lispro.
Product ID | 0002-8798_1bcd1f36-e53f-4006-b31b-1c78d29ae380 |
NDC | 0002-8798 |
Product Type | Human Prescription Drug |
Proprietary Name | Humalog Mix50/50 KwikPen |
Generic Name | Insulin Lispro |
Dosage Form | Injection, Suspension |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2007-09-06 |
Marketing Category | NDA / NDA |
Application Number | NDA021018 |
Labeler Name | Eli Lilly and Company |
Substance Name | INSULIN LISPRO |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2008-01-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA021018 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-01-16 |
Marketing Category | BLA |
Application Number | BLA021018 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2007-09-06 |
Marketing Category | BLA |
Application Number | BLA021018 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-01-16 |
Ingredient | Strength |
---|---|
INSULIN LISPRO | 100 [iU]/mL |
SPL SET ID: | b34cd3ff-d0af-4852-b4ef-2a8b4a93aeae |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0002-8798 | Humalog Mix50/50 KwikPen | Humalog Mix50/50 KwikPen |
0002-7510 | Humalog | Insulin lispro |
0002-7511 | Humalog | Insulin lispro |
0002-7512 | Humalog | Insulin lispro |
0002-7516 | Humalog | Insulin lispro |
0002-7712 | Humalog | Insulin lispro |
0002-7714 | Humalog | Insulin lispro |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HUMALOG 74314093 1963572 Live/Registered |
Eli Lilly and Company 1992-09-15 |